KRM Ayurveda IPO entered the primary market as a Book Built SME issue by KRM Ayurveda Limited. Through this public offering, the company issued fresh equity shares to raise capital for expanding its healthcare network and supporting future business development. According to the company’s stated plans, the IPO proceeds were proposed to be utilised for strengthening telemedicine services, upgrading technology infrastructure, meeting additional working capital requirements, repaying certain borrowings, expanding its workforce, and supporting general corporate activities. After the completion of the allotment process, the company’s equity shares were listed on the NSE SME platform.
KRM Ayurveda Limited operates in the Ayurveda healthcare sector by providing treatment and wellness services based on traditional Ayurvedic principles. The company offers healthcare solutions through its hospitals, clinics, consultation centres, and digital healthcare platform, serving patients across different parts of India as well as selected international markets. Its services include outpatient consultations, inpatient treatment, Panchakarma therapies, pharmacy support, and personalised wellness programmes designed to address various health conditions.
The company’s operations extend across patient consultation, diagnosis, treatment planning, medicine dispensing, therapeutic procedures, follow-up care, and digital healthcare services. Alongside physical healthcare facilities, KRM Ayurveda has also developed teleconsultation services that enable patients to access Ayurvedic consultations and treatment guidance remotely. This integrated healthcare model allows the company to improve accessibility while maintaining continuity of patient care.
KRM Ayurveda follows a business strategy centred on expanding its healthcare infrastructure, enhancing digital healthcare capabilities, and improving service quality. The company continues to invest in medical professionals, healthcare technology, operational systems, and patient support services to strengthen its presence in the organised Ayurveda healthcare segment. Its long-term objective is to increase patient reach while maintaining consistent standards of treatment and healthcare delivery.
India’s Ayurveda and wellness industry continues to witness steady growth due to increasing awareness of preventive healthcare, greater acceptance of traditional treatment systems, rising lifestyle-related health concerns, and growing consumer preference for natural wellness solutions. Government initiatives promoting AYUSH healthcare, along with the increasing adoption of online healthcare services, are creating favourable opportunities for organised Ayurveda healthcare providers across the country.
Since the IPO has already been completed and the company’s shares are listed on the stock exchange, investors should evaluate the company’s financial performance, healthcare operations, expansion strategy, industry outlook, competitive strengths, and valuation before making any long-term investment decision.
KRM Ayurveda IPO Details
| IPO Details | Information |
|---|---|
| IPO Name | KRM Ayurveda IPO |
| Company Name | KRM Ayurveda Limited |
| IPO Type | Book Built Issue |
| IPO Category | SME IPO |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹128 to ₹135 Per Share |
| Issue Size | ₹77.49 Crore |
| Fresh Issue | 57,40,000 Equity Shares |
| Offer for Sale | Nil |
| Total Shares Offered | 57,40,000 Equity Shares |
| IPO Open Date | 21 January 2026 |
| IPO Close Date | 23 January 2026 |
| Basis of Allotment | 27 January 2026 |
| Refund Initiation | 28 January 2026 |
| Shares Credited to Demat Account | 28 January 2026 |
| Listing Date | 29 January 2026 |
| Listing Exchange | NSE SME |
| Lot Size | 1,000 Equity Shares |
| Registrar | Skyline Financial Services Private Limited |
| Book Running Lead Manager | Nexgen Financial Solutions Private Limited |
The public issue comprised only a fresh issue of equity shares, and no existing shareholder participated through an offer for sale. The funds mobilised from the IPO were planned to support healthcare expansion, strengthen digital medical services, improve technology infrastructure, meet working capital needs, reduce certain borrowings, and finance general business requirements. These initiatives are intended to enhance operational capabilities and support the company’s long-term growth strategy.
KRM Ayurveda IPO Dates
The key events related to the KRM Ayurveda IPO are provided below.
| IPO Event | Date |
|---|---|
| IPO Opening Date | 21 January 2026 |
| IPO Closing Date | 23 January 2026 |
| Basis of Allotment | 27 January 2026 |
| Refund Initiation | 28 January 2026 |
| Shares Credited to Demat Account | 28 January 2026 |
| Listing Date | 29 January 2026 |
After the allotment process was completed, successful applicants received the allotted equity shares in their demat accounts before trading commenced on the NSE SME platform. Applicants who did not receive an allotment were issued refunds according to the prescribed IPO schedule.
KRM Ayurveda IPO Reservation
The equity shares offered through the public issue were reserved for different categories of investors in accordance with the SME IPO regulations applicable at the time of the issue.
| Investor Category | Reservation |
|---|---|
| Qualified Institutional Buyers (QIB) | Not More Than 50% |
| Non-Institutional Investors (NII) | Not Less Than 15% |
| Retail Individual Investors (RII) | Not Less Than 35% |
The final allocation under each investor category depended on the number of valid bids received during the subscription period and the applicable regulatory guidelines governing SME public issues.
KRM Ayurveda IPO Lot Size
Applications for the IPO were accepted only in the prescribed lot size announced before the issue opened for subscription.
| Application | Shares | Amount |
|---|---|---|
| Retail Minimum | 1 Lot (1,000 Shares) | ₹1,35,000 |
| Retail Maximum | 1 Lot (1,000 Shares) | ₹1,35,000 |
| HNI Minimum | 2 Lots (2,000 Shares) | ₹2,70,000 |
The investment values shown above are calculated using the upper price band of ₹135 per equity share. Investors were required to apply in multiples of the specified lot size while submitting their IPO applications.
About KRM Ayurveda Limited
KRM Ayurveda Limited is an Indian healthcare company engaged in providing Ayurvedic treatment and wellness services through hospitals, clinics, consultation centres, and digital healthcare platforms. The company focuses on delivering healthcare solutions based on traditional Ayurvedic principles while integrating organised clinical practices and modern patient management systems. Its services are designed to address both chronic health conditions and preventive healthcare requirements for patients across different age groups.
The company offers a wide range of healthcare services that include medical consultations, inpatient and outpatient treatment, Panchakarma therapies, Ayurvedic medicines, wellness programmes, diagnostic support, and follow-up care. By combining experienced Ayurvedic practitioners with structured treatment protocols, KRM Ayurveda aims to provide personalised healthcare solutions based on individual patient needs.
Apart from its physical healthcare facilities, the company has also expanded its digital healthcare capabilities through telemedicine and online consultation services. These initiatives enable patients from different locations to access Ayurvedic consultation, treatment guidance, and medicine delivery without visiting a healthcare centre. The company continues to strengthen its healthcare network by investing in medical infrastructure, technology, and operational efficiency to improve patient accessibility and service quality.
Business Operations
KRM Ayurveda Limited operates across various segments of the Ayurveda healthcare and wellness industry.
- Ayurvedic Consultations – The company provides medical consultations through qualified Ayurvedic doctors for the diagnosis and treatment of various health conditions.
- Hospital Services – It operates healthcare facilities that offer inpatient and outpatient treatment supported by Ayurvedic therapies and medical supervision.
- Panchakarma Therapy – The company provides traditional Panchakarma procedures designed for detoxification, rejuvenation, and overall wellness.
- Telemedicine Services – Patients can access online consultations, treatment guidance, and healthcare support through the company’s digital healthcare platform.
- Ayurvedic Pharmacy – The company supplies Ayurvedic medicines and healthcare products prescribed during treatment and follow-up care.
- Wellness Programmes – Specialised wellness services include preventive healthcare, lifestyle management, dietary counselling, yoga guidance, and health improvement programmes.
- Chronic Disease Management – The company offers Ayurvedic treatment programmes for various chronic and lifestyle-related health conditions through customised care plans.
- Healthcare Infrastructure – Medical services are supported by hospitals, consultation centres, therapy units, pharmacy facilities, and patient support systems.
- Patient Support Services – Continuous follow-up consultations, treatment monitoring, counselling, and healthcare assistance help improve patient outcomes.
- Technology Integration – The company continues to enhance healthcare delivery by adopting digital healthcare systems, teleconsultation services, and technology-driven patient management.
Industry Overview
India’s Ayurveda and wellness industry has grown steadily over the past several years due to increasing consumer awareness regarding preventive healthcare and natural treatment methods. More individuals are adopting Ayurvedic therapies and wellness programmes as part of their long-term health management, creating greater demand for organised healthcare providers operating in this segment.
Government initiatives supporting the AYUSH sector, improvements in healthcare infrastructure, and wider acceptance of traditional medicine have contributed to the industry’s expansion. The increasing popularity of telemedicine, online consultations, and digital healthcare platforms has further improved patient access to Ayurvedic treatment across urban as well as rural markets.
The industry is also benefiting from rising demand for herbal medicines, wellness therapies, lifestyle management programmes, and preventive healthcare services. Companies that continue to invest in healthcare infrastructure, qualified practitioners, technology integration, and patient-focused services are well positioned to benefit from the long-term growth opportunities within the organised Ayurveda healthcare sector.
Business Strategy
KRM Ayurveda Limited aims to strengthen its position by expanding its healthcare network, improving treatment facilities, and enhancing digital healthcare services. The company continues to invest in hospital infrastructure, telemedicine capabilities, technology systems, and qualified healthcare professionals to improve operational efficiency and patient experience.
The management also focuses on expanding specialised treatment programmes, strengthening patient outreach, and improving access to Ayurvedic healthcare across different geographical regions. Continuous investment in healthcare technology, service quality, and operational systems supports the company’s objective of achieving sustainable long-term growth.
By combining traditional Ayurvedic practices with organised healthcare management and digital healthcare solutions, KRM Ayurveda Limited seeks to strengthen its presence in India’s growing Ayurveda and wellness industry while delivering quality healthcare services to a larger patient base.
KRM Ayurveda IPO Financial Information
The financial performance of a company helps investors evaluate its business growth, operational efficiency, profitability, and overall financial position. Analysing financial statements over multiple financial years provides a clearer understanding of revenue trends, earnings growth, capital utilisation, and the company’s ability to sustain future expansion. Investors should always consider financial performance together with business fundamentals and industry outlook before making an investment decision.
KRM Ayurveda Financial Summary
| Particulars | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue from Operations | ₹72.84 Crore | ₹98.17 Crore | ₹128.94 Crore |
| Total Income | ₹73.26 Crore | ₹99.01 Crore | ₹130.08 Crore |
| EBITDA | ₹13.48 Crore | ₹18.79 Crore | ₹26.54 Crore |
| Profit Before Tax (PBT) | ₹8.17 Crore | ₹12.46 Crore | ₹18.68 Crore |
| Profit After Tax (PAT) | ₹6.12 Crore | ₹9.34 Crore | ₹14.03 Crore |
| Net Worth | ₹28.94 Crore | ₹38.28 Crore | ₹52.31 Crore |
| Total Borrowings | ₹18.46 Crore | ₹17.29 Crore | ₹15.74 Crore |
KRM Ayurveda Limited has reported consistent financial growth during the last three financial years. The company recorded steady growth in revenue while improving its profitability and strengthening its net worth. At the same time, borrowings remained under control, reflecting disciplined financial management. Investors should analyse these financial results along with the company’s healthcare network, expansion strategy, industry outlook, and future earnings potential before making an investment decision.
KRM Ayurveda IPO Key Performance Indicators (KPIs)
Key Performance Indicators help investors assess the company’s profitability, operational efficiency, financial strength, and valuation. These ratios provide additional insights into how effectively the company generates returns and utilises shareholders’ capital.
| KPI | Value |
|---|---|
| Return on Equity (ROE) | 26.82% |
| Return on Capital Employed (ROCE) | 28.67% |
| Return on Net Worth (RONW) | 26.82% |
| EBITDA Margin | 20.40% |
| PAT Margin | 10.79% |
| Debt-to-Equity Ratio | 0.30 |
| Earnings Per Share (EPS) | ₹8.94 |
| Net Asset Value (NAV) Per Share | ₹33.86 |
| Price to Earnings (P/E) | 15.10x |
The company’s financial ratios indicate healthy profitability, improving operating margins, and efficient utilisation of capital. A moderate debt level and increasing return ratios further strengthen its financial profile. However, investors should consider these indicators together with the company’s valuation, competitive position, expansion plans, and long-term growth prospects before making any investment decision.
Objects of the KRM Ayurveda IPO
The company proposed to utilise the net proceeds from the fresh issue for the following purposes:
- Expansion of telemedicine facilities.
- Upgrading technology infrastructure.
- Meeting working capital requirements.
- Repayment or prepayment of certain borrowings.
- Human resource expansion.
- General corporate purposes.
The proposed utilisation of the IPO proceeds is expected to strengthen the company’s healthcare infrastructure, improve digital healthcare capabilities, support business expansion, and enhance operational efficiency. These investments are intended to support the company’s long-term growth strategy while expanding access to its Ayurveda healthcare services.
KRM Ayurveda IPO Listing Performance
The listing performance indicates how the company’s shares performed when they started trading on the stock exchange after the IPO process was completed. Although listing gains or discounts reflect the market’s initial response to the public issue, long-term investment performance generally depends on the company’s financial growth, operational execution, business strategy, and future expansion plans.
| Particular | Value |
|---|---|
| Listing Exchange | NSE SME |
| Listing Date | 29 January 2026 |
| Issue Price | ₹135 Per Share |
| Listing Price | ₹148.50 Per Share |
| Listing Gain | ₹13.50 Per Share |
| Listing Gain (%) | 10.00% |
KRM Ayurveda Limited made a positive debut on the NSE SME platform by listing above its issue price. While the listing premium reflected healthy investor interest, long-term returns will depend on the company’s financial performance, healthcare expansion, operational efficiency, and ability to execute its growth strategy.
KRM Ayurveda IPO Subscription Status
The subscription details provide an overview of investor participation during the IPO bidding period. Strong subscription levels generally indicate positive market interest; however, investors should evaluate the company’s financial performance, valuation, competitive position, and long-term business prospects before making any investment decision.
KRM Ayurveda IPO Subscription
| Investor Category | Subscription |
|---|---|
| Qualified Institutional Buyers (QIB) | 61.84 Times |
| Non-Institutional Investors (NII) | 143.57 Times |
| Retail Individual Investors (RII) | 95.42 Times |
| Total Subscription | 91.28 Times |
The IPO received strong demand across all investor categories. Non-Institutional Investors recorded the highest level of participation, while Qualified Institutional Buyers and Retail Individual Investors also subscribed to the issue multiple times. The robust overall subscription reflected broad investor confidence in the public offering.
KRM Ayurveda IPO Review
KRM Ayurveda Limited operates in the organised Ayurveda healthcare sector by offering medical consultation, hospital-based treatment, Panchakarma therapies, wellness programmes, telemedicine services, and Ayurvedic pharmacy solutions. The company combines traditional Ayurvedic healthcare practices with organised clinical management to provide comprehensive treatment for patients suffering from chronic and lifestyle-related health conditions.
The company’s healthcare network is supported by hospitals, consultation centres, qualified Ayurvedic practitioners, digital healthcare platforms, and patient support services. Continuous investment in healthcare infrastructure, technology, and telemedicine enables the company to improve patient accessibility while strengthening its service offerings across multiple regions.
From a financial perspective, the company has reported steady growth in revenue and profitability during recent financial years. The proposed utilisation of IPO proceeds towards technology upgrades, telemedicine expansion, working capital, debt reduction, and organisational development is expected to support future business expansion and operational efficiency.
However, investors should also consider factors such as regulatory compliance, competition within the healthcare industry, dependence on qualified healthcare professionals, changing consumer preferences, and execution of expansion plans before making an investment decision.
Overall, KRM Ayurveda Limited operates in a growing healthcare segment supported by increasing awareness of preventive healthcare and rising demand for traditional wellness solutions. Investors should carefully evaluate the company’s financial performance, valuation, business strategy, and long-term growth prospects before considering an investment.
KRM Ayurveda IPO Strengths
KRM Ayurveda Limited has established its presence in the organised Ayurveda healthcare sector through diversified healthcare services and continuous investment in patient care.
- Established presence in the Ayurveda healthcare and wellness industry.
- Diversified healthcare services through hospitals, clinics, and telemedicine platforms.
- Experienced healthcare professionals and structured treatment programmes.
- Consistent growth in revenue and profitability over recent financial years.
- Focus on digital healthcare expansion and technology integration.
- Benefits from increasing demand for Ayurveda and preventive healthcare services.
KRM Ayurveda IPO Risk Factors
Like other healthcare companies, KRM Ayurveda Limited is exposed to several operational and industry-related risks that investors should evaluate carefully.
- The business operates in a highly regulated healthcare environment.
- Competition from organised hospitals, wellness centres, and Ayurveda healthcare providers may affect future growth.
- Expansion plans require efficient execution and effective utilisation of capital.
- The company depends on experienced healthcare professionals to maintain service quality.
- Changes in healthcare regulations or government policies may influence business operations.
- Rising operating costs and continued investment in healthcare infrastructure could impact future profitability.
KRM Ayurveda IPO Promoters
KRM Ayurveda Limited is promoted by individuals with experience in the Ayurveda healthcare and wellness sector. The promoters have played an important role in developing the company’s healthcare network, expanding its treatment facilities, and strengthening its presence in the organised Ayurveda industry. Their focus remains on improving healthcare services, expanding digital healthcare capabilities, and supporting the company’s long-term growth strategy.
KRM Ayurveda IPO Promoters Details
| Promoter | Designation |
|---|---|
| Dr. Ramakant Mishra | Promoter & Managing Director |
| Dr. Kavita Mishra | Promoter & Whole-Time Director |
KRM Ayurveda IPO Management Team
The company is managed by experienced professionals responsible for healthcare operations, hospital administration, finance, compliance, and business development. The management team focuses on expanding healthcare infrastructure, improving patient care, strengthening operational efficiency, and supporting sustainable business growth.
| Name | Designation |
|---|---|
| Dr. Ramakant Mishra | Managing Director |
| Dr. Kavita Mishra | Whole-Time Director |
| Amit Kumar | Chief Financial Officer |
| Neha Sharma | Company Secretary & Compliance Officer |
KRM Ayurveda IPO Registrar Details
The registrar managed the IPO application process, finalised the basis of allotment, credited shares to successful applicants, initiated refunds where applicable, and handled investor-related services during the public issue.
| Particular | Details |
|---|---|
| Registrar Name | Skyline Financial Services Private Limited |
| Website | https://www.skylinerta.com |
| IPO Allotment Status | https://www.skylinerta.com/ipo.php |
| Email ID | [email protected] |
| Contact Number | +91-11-4045 0193 |
KRM Ayurveda IPO Lead Manager Details
The Book Running Lead Manager coordinated the public issue, managed regulatory compliance, assisted with marketing activities, and supported the company throughout the IPO and listing process.
| Particular | Details |
|---|---|
| Lead Manager | Nexgen Financial Solutions Private Limited |
| Website | https://www.nexgenfin.com/ |
| Email ID | [email protected] |
| Contact Number | +91-79-4002 8888 |
KRM Ayurveda Limited Contact Details
| Particular | Details |
|---|---|
| Company Name | KRM Ayurveda Limited |
| Registered Office | New Delhi, India |
| Website | https://www.krmayurveda.com |
| Email ID | [email protected] |
How to Check KRM Ayurveda IPO Allotment Status
Investors could check the IPO allotment status after the basis of allotment was finalised through the registrar’s website or the NSE IPO portal.
Through Skyline Financial Services Private Limited
- Visit the official IPO allotment portal of Skyline Financial Services Private Limited.
- Select KRM Ayurveda IPO from the list of available IPOs.
- Choose any one of the available search options such as PAN Number, Application Number, or DP/Client ID.
- Enter the required details in the respective field.
- Click on Search to view the allotment status.
Through NSE
- Visit the official NSE IPO allotment page.
- Select KRM Ayurveda IPO from the list of available public issues.
- Enter your Application Number, PAN, or DP/Client ID.
- Complete the verification process.
- Click on Submit to check your allotment status.
Frequently Asked Questions (FAQs)
What is the KRM Ayurveda IPO?
KRM Ayurveda IPO was a Book Built SME public issue through which the company raised funds by issuing fresh equity shares.
What was the price band of the KRM Ayurveda IPO?
The IPO was offered at a price band of ₹128 to ₹135 per equity share.
What was the issue size of the KRM Ayurveda IPO?
The total issue size of the IPO was ₹77.49 Crore.
When did the KRM Ayurveda IPO open and close?
The IPO opened for subscription on 21 January 2026 and closed on 23 January 2026.
On which stock exchange are KRM Ayurveda shares listed?
The company’s equity shares are listed on the NSE SME platform.
Who was the registrar for the KRM Ayurveda IPO?
Skyline Financial Services Private Limited acted as the registrar to the issue.
Who was the Book Running Lead Manager for the KRM Ayurveda IPO?
The IPO was managed by Nexgen Financial Solutions Private Limited as the Book Running Lead Manager.
What was the minimum lot size for the KRM Ayurveda IPO?
The minimum application size was 1,000 equity shares.
The minimum application size was 1,000 equity shares.
The company provides Ayurveda-based healthcare services through hospitals, clinics, telemedicine platforms, wellness programmes, Panchakarma therapies, and Ayurvedic pharmacy services.
What were the objectives of the KRM Ayurveda IPO?
The company proposed to utilise the IPO proceeds for expanding telemedicine services, upgrading technology infrastructure, meeting working capital requirements, repaying certain borrowings, supporting human resource expansion, and general corporate purposes.
